These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1151 related items for PubMed ID: 16919430

  • 1. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
    Yasuda T, Tchetina E, Ohsawa K, Roughley PJ, Wu W, Mousa A, Ionescu M, Pidoux I, Poole AR.
    Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
    [Abstract] [Full Text] [Related]

  • 2. Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: implications for development and arthritis.
    Tchetina EV, Kobayashi M, Yasuda T, Meijers T, Pidoux I, Poole AR.
    Matrix Biol; 2007 May; 26(4):247-58. PubMed ID: 17306969
    [Abstract] [Full Text] [Related]

  • 3. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
    Yasuda T, Poole AR.
    Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
    [Abstract] [Full Text] [Related]

  • 4. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, Reiner A, Tanzer M, Zukor D, Chen J, van Wart HE, Poole AR.
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [Abstract] [Full Text] [Related]

  • 5. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB, Flannery CR, Hughes CE, Mort JS, Roughley PJ, Dent C, Caterson B.
    Biochem J; 1999 Nov 15; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC, Wu W, Ionescu M, Reiner A, Dahlberg L, Chen J, van Wart H, Poole AR.
    Arthritis Rheum; 2000 Mar 15; 43(3):664-72. PubMed ID: 10728761
    [Abstract] [Full Text] [Related]

  • 7. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13.
    Wu W, Billinghurst RC, Pidoux I, Antoniou J, Zukor D, Tanzer M, Poole AR.
    Arthritis Rheum; 2002 Aug 15; 46(8):2087-94. PubMed ID: 12209513
    [Abstract] [Full Text] [Related]

  • 8. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions.
    Tchetina EV, Squires G, Poole AR.
    J Rheumatol; 2005 May 15; 32(5):876-86. PubMed ID: 15868625
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy.
    Tchetina EV, Di Battista JA, Zukor DJ, Antoniou J, Poole AR.
    Arthritis Res Ther; 2007 May 15; 9(4):R75. PubMed ID: 17683641
    [Abstract] [Full Text] [Related]

  • 10. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.
    Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, Chen J, Van Wart H, Poole AR.
    J Clin Invest; 1997 Apr 01; 99(7):1534-45. PubMed ID: 9119997
    [Abstract] [Full Text] [Related]

  • 11. Involvement of CD44 in induction of matrix metalloproteinases by a COOH-terminal heparin-binding fragment of fibronectin in human articular cartilage in culture.
    Yasuda T, Poole AR, Shimizu M, Nakagawa T, Julovi SM, Tamamura H, Fujii N, Nakamura T.
    Arthritis Rheum; 2003 May 01; 48(5):1271-80. PubMed ID: 12746900
    [Abstract] [Full Text] [Related]

  • 12. Gene expression of single articular chondrocytes.
    Eleswarapu SV, Leipzig ND, Athanasiou KA.
    Cell Tissue Res; 2007 Jan 01; 327(1):43-54. PubMed ID: 16944207
    [Abstract] [Full Text] [Related]

  • 13. Collagen degradation products modulate matrix metalloproteinase expression in cultured articular chondrocytes.
    Fichter M, Körner U, Schömburg J, Jennings L, Cole AA, Mollenhauer J.
    J Orthop Res; 2006 Jan 01; 24(1):63-70. PubMed ID: 16419970
    [Abstract] [Full Text] [Related]

  • 14. Activation of cartilage matrix metalloproteinases by activated protein C.
    Jackson MT, Smith MM, Smith SM, Jackson CJ, Xue M, Little CB.
    Arthritis Rheum; 2009 Mar 01; 60(3):780-91. PubMed ID: 19248107
    [Abstract] [Full Text] [Related]

  • 15. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
    Squires GR, Okouneff S, Ionescu M, Poole AR.
    Arthritis Rheum; 2003 May 01; 48(5):1261-70. PubMed ID: 12746899
    [Abstract] [Full Text] [Related]

  • 16. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
    Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U, Poole AR.
    Arthritis Rheum; 2005 Jan 01; 52(1):128-35. PubMed ID: 15641080
    [Abstract] [Full Text] [Related]

  • 17. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, Singer II, Donatelli SA, Weidner JR, Williams HR, Mumford RA, Lohmander LS.
    J Clin Invest; 1997 Jul 01; 100(1):93-106. PubMed ID: 9202061
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes.
    Hui A, Min WX, Tang J, Cruz TF.
    Arthritis Rheum; 1998 May 01; 41(5):869-76. PubMed ID: 9588740
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of atorvastatin in cultured osteoarthritic chondrocytes.
    Simopoulou T, Malizos KN, Poultsides L, Tsezou A.
    J Orthop Res; 2010 Jan 01; 28(1):110-5. PubMed ID: 19623662
    [Abstract] [Full Text] [Related]

  • 20. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, Emery P, Poole AR, Veale DJ.
    Arthritis Rheum; 2003 Nov 01; 48(11):3085-95. PubMed ID: 14613270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.